Clinical trials and opportunities
Clinical trials play a crucial role in advancing our understanding of Sjögren’s disease and improving treatment options for those living with the condition. They provide researchers with the opportunity to study the disease in depth, evaluate new therapies, and gain insights that can lead to better care and, ultimately, a potential cure. For patients, participating in clinical trials can offer access to innovative treatments, contribute to medical knowledge, and help shape the future of Sjögren’s care.
At Sjögren’s Australia, we recognise the importance of ensuring that all clinical trial opportunities are both safe and meaningful. Each trial is carefully reviewed and vetted by our Medical Panel, which comprises experienced healthcare professionals with expertise in Sjögren’s disease. This rigorous process ensures that trials align with our commitment to safety, scientific integrity, and the best interests of our community.
We also aim to keep patients informed and empowered, providing clear and accessible information about available trials, eligibility criteria, and what participation involves. By supporting clinical research and encouraging responsible participation, Sjögren’s Australia helps accelerate the development of effective treatments and improves the overall understanding of this complex autoimmune condition.
Together, we can drive progress and hope for all Australians affected by Sjögren’s disease.
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
The main purpose of this study is to find out how a medicine called nerandomilast affects the lungs in people with systemic autoimmune rheumatic disease.
Boehringer Ingelheim / various locations
Dry eye clinical trial
Study recruiting adults with dry eye disease to investigate the effects of 0.1% ciclosporin A eye drops on immune cells at the surface of the eye over a 12‑week treatment period.
UNSW Sydney - NSW
Sjögren’s Dry Eye Study
Lubris BioPharma is recruiting adults with Sjögren’s disease and dry eye disease to evaluate the safety and effectiveness of an investigational eye drop treatment through a two-month clinical research study.
Lubris BioPharma - VIC, NSW, QLD (Various)
Investigational Dry Eye Treatment
Researchers are recruiting adults with Sjögren’s related dry eye disease for a Phase 2 clinical trial evaluating the safety and effectiveness of an investigational rhPRG4 eye drop treatment.
Lubris Bio Pty Ltd - VIC, NSW, QLD (various)
Have your say on access to specialist care
For people living with Sjögren’s, accessing the right specialists can involve long waiting times, high costs, referral difficulties and significant travel.
A Federal Parliament inquiry is examining access to and affordability of medical specialists in Australia. Global Healthy Living Foundation Australia is inviting patients to share their experiences both the challenges and what has worked well.
Your experience can help inform its submission and advocate for a more accessible, affordable healthcare system. Comments will be used without information that identifies you.